A trio of Democrats on the Senate health committee, led by presidential candidate Elizabeth Warren (D-Mass.), is reiterating concerns with the way the Food and Drug Administration is beginning to regulate certain smartphone apps and other digital health software.

Over the past two years, the agency has been working closely with companies such as Apple and Fitbit to develop and test out a precertification program, known as “Pre-cert,” to streamline regulation of certain low-risk digital health products. The idea is to shift the FDA’s focus from evaluating digital-health products to evaluating their makers, allowing companies with internal processes that the agency deems safe and high-quality to build some additional products that can reach the market with less or perhaps no regulation.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy